Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Drug and Delivery Technologies Market 2018, Forecast to 2023

Publisher Name :
Date: 25-Jun-2018
No. of pages: 130

Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of  diabetes such as  diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.

Scope of the Report:

This report focuses on the Insulin Drug and Delivery Technologies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. 

The worldwide market for Insulin Drug and Delivery Technologies is expected to grow at a CAGR of roughly 9.2% over the next five years, will reach 55900 million US$ in 2023, from 36000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Eli Lilly and Company

- Biocon

- Julphar

- Ypsomed

- Becton, Dickinson and Company

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Insulin Syringes

- Insulin Vials

- Insulin Pens

- Insulin Pumps

Market Segment by Applications, can be divided into

- Diabetes Mellitus Type 1

- Diabetes Mellitus Type 2

- Gestational Diabetes

There are 15 Chapters to deeply display the global Insulin Drug and Delivery Technologies market.

Chapter 1, to describe Insulin Drug and Delivery Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Drug and Delivery Technologies, with sales, revenue, and price of Insulin Drug and Delivery Technologies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Drug and Delivery Technologies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Insulin Drug and Delivery Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Insulin Drug and Delivery Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Drug and Delivery Technologies Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Insulin Drug and Delivery Technologies Introduction
1.2 Market Analysis by Type
1.2.1 Insulin Syringes
1.2.2 Insulin Vials
1.2.3 Insulin Pens
1.2.4 Insulin Pumps
1.3 Market Analysis by Applications
1.3.1 Diabetes Mellitus Type 1
1.3.2 Diabetes Mellitus Type 2
1.3.3 Gestational Diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.1.1 Sanofi Description
2.1.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.1.2 Sanofi Insulin Drug and Delivery Technologies Product Introduction
2.1.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.1.2.2 Insulin Drug and Delivery Technologies Product Information
2.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Sanofi Insulin Drug and Delivery Technologies Market Share in 2017
2.2 Eli Lilly and Company
2.2.1 Business Overview
2.2.1.1 Eli Lilly and Company Description
2.2.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview
2.2.2 Eli Lilly and Company Insulin Drug and Delivery Technologies Product Introduction
2.2.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.2.2.2 Insulin Drug and Delivery Technologies Product Information
2.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Eli Lilly and Company Insulin Drug and Delivery Technologies Market Share in 2017
2.3 Biocon
2.3.1 Business Overview
2.3.1.1 Biocon Description
2.3.1.2 Biocon Headquarter, Main Business and Finance Overview
2.3.2 Biocon Insulin Drug and Delivery Technologies Product Introduction
2.3.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.3.2.2 Insulin Drug and Delivery Technologies Product Information
2.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Biocon Insulin Drug and Delivery Technologies Market Share in 2017
2.4 Julphar
2.4.1 Business Overview
2.4.1.1 Julphar Description
2.4.1.2 Julphar Headquarter, Main Business and Finance Overview
2.4.2 Julphar Insulin Drug and Delivery Technologies Product Introduction
2.4.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.4.2.2 Insulin Drug and Delivery Technologies Product Information
2.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Julphar Insulin Drug and Delivery Technologies Market Share in 2017
2.5 Ypsomed
2.5.1 Business Overview
2.5.1.1 Ypsomed Description
2.5.1.2 Ypsomed Headquarter, Main Business and Finance Overview
2.5.2 Ypsomed Insulin Drug and Delivery Technologies Product Introduction
2.5.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.5.2.2 Insulin Drug and Delivery Technologies Product Information
2.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Ypsomed Insulin Drug and Delivery Technologies Market Share in 2017
2.6 Becton, Dickinson and Company
2.6.1 Business Overview
2.6.1.1 Becton, Dickinson and Company Description
2.6.1.2 Becton, Dickinson and Company Headquarter, Main Business and Finance Overview
2.6.2 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product Introduction
2.6.2.1 Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
2.6.2.2 Insulin Drug and Delivery Technologies Product Information
2.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Becton, Dickinson and Company Insulin Drug and Delivery Technologies Market Share in 2017
3 Global Insulin Drug and Delivery Technologies Market Competition, by Manufacturer
3.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Insulin Drug and Delivery Technologies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017
3.4.2 Top 5 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Insulin Drug and Delivery Technologies Market Analysis by Regions
4.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Drug and Delivery Technologies Sales by Regions (2013-2018)
4.1.2 Global Insulin Drug and Delivery Technologies Revenue by Regions (2013-2018)
4.2 North America Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2013-2018)
5 North America Insulin Drug and Delivery Technologies by Countries, Type, Application and Manufacturers
5.1 North America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
5.1.1 North America Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
5.1.2 North America Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
5.1.3 United States Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5.1.4 Canada Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5.1.5 Mexico Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
5.2 North America Insulin Drug and Delivery Technologies Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Insulin Drug and Delivery Technologies Sales by Manufacturers (2016-2017)
5.2.2 North America Insulin Drug and Delivery Technologies Revenue by Manufacturers (2016-2017)
5.3 North America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Insulin Drug and Delivery Technologies Sales and Sales Share by Type (2013-2018)
5.3.2 North America Insulin Drug and Delivery Technologies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Insulin Drug and Delivery Technologies Sales and Sales Share by Application (2013-2018)
5.4.2 North America Insulin Drug and Delivery Technologies Revenue and Revenue Share by Application (2013-2018)
6 Europe Insulin Drug and Delivery Technologies by Countries, Type, Application and Manufacturers
6.1 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
6.1.1 Europe Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
6.1.2 Europe Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
6.1.3 Germany Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.1.4 UK Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.1.5 France Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.1.6 Russia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.1.7 Italy Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
6.2 Europe Insulin Drug and Delivery Technologies Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Insulin Drug and Delivery Technologies Sales by Manufacturers (2016-2017)
6.2.2 Europe Insulin Drug and Delivery Technologies Revenue by Manufacturers (2016-2017)
6.3 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Insulin Drug and Delivery Technologies Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Insulin Drug and Delivery Technologies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Insulin Drug and Delivery Technologies Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Insulin Drug and Delivery Technologies Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Insulin Drug and Delivery Technologies by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
7.1.3 China Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.1.4 Japan Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.1.5 Korea Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.1.6 India Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Revenue Share by Application (2013-2018)
8 South America Insulin Drug and Delivery Technologies by Countries, Type, Application and Manufacturers
8.1 South America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
8.1.1 South America Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
8.1.2 South America Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
8.1.3 Brazil Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8.1.4 Argentina Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8.1.5 Colombia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
8.2 South America Insulin Drug and Delivery Technologies Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Insulin Drug and Delivery Technologies Sales by Manufacturers (2016-2017)
8.2.2 South America Insulin Drug and Delivery Technologies Revenue by Manufacturers (2016-2017)
8.3 South America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Insulin Drug and Delivery Technologies Sales and Sales Share by Type (2013-2018)
8.3.2 South America Insulin Drug and Delivery Technologies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Insulin Drug and Delivery Technologies Sales and Sales Share by Application (2013-2018)
8.4.2 South America Insulin Drug and Delivery Technologies Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Insulin Drug and Delivery Technologies by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.1.4 UAE Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.1.5 Egypt Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.1.7 South Africa Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Insulin Drug and Delivery Technologies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue and Revenue Share by Application (2013-2018)
10 Global Insulin Drug and Delivery Technologies Market Segment by Type
10.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Type (2013-2018)
10.1.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Type (2013-2018)
10.2 Insulin Syringes Sales Growth and Price
10.2.1 Global Insulin Syringes Sales Growth (2013-2018)
10.2.2 Global Insulin Syringes Price (2013-2018)
10.3 Insulin Vials Sales Growth and Price
10.3.1 Global Insulin Vials Sales Growth (2013-2018)
10.3.2 Global Insulin Vials Price (2013-2018)
10.4 Insulin Pens Sales Growth and Price
10.4.1 Global Insulin Pens Sales Growth (2013-2018)
10.4.2 Global Insulin Pens Price (2013-2018)
10.5 Insulin Pumps Sales Growth and Price
10.5.1 Global Insulin Pumps Sales Growth (2013-2018)
10.5.2 Global Insulin Pumps Price (2013-2018)
11 Global Insulin Drug and Delivery Technologies Market Segment by Application
11.1 Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2013-2018)
11.2 Diabetes Mellitus Type 1 Sales Growth (2013-2018)
11.3 Diabetes Mellitus Type 2 Sales Growth (2013-2018)
11.4 Gestational Diabetes Sales Growth (2013-2018)
12 Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2018-2023)
12.2 Insulin Drug and Delivery Technologies Market Forecast by Regions (2018-2023)
12.2.1 North America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.2 Europe Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.4 South America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Insulin Drug and Delivery Technologies Market Forecast (2018-2023)
12.3 Insulin Drug and Delivery Technologies Market Forecast by Type (2018-2023)
12.3.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Type (2018-2023)
12.3.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Type (2018-2023)
12.4 Insulin Drug and Delivery Technologies Market Forecast by Application (2018-2023)
12.4.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Application (2018-2023)
12.4.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Insulin Drug and Delivery Technologies Picture
Table Product Specifications of Insulin Drug and Delivery Technologies
Figure Global Insulin Drug and Delivery Technologies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Insulin Drug and Delivery Technologies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Insulin Drug and Delivery Technologies by Types in 2017
Figure Insulin Syringes Picture
Table Major Manufacturers of Insulin Syringes
Figure Insulin Vials Picture
Table Major Manufacturers of Insulin Vials
Figure Insulin Pens Picture
Table Major Manufacturers of Insulin Pens
Figure Insulin Pumps Picture
Table Major Manufacturers of Insulin Pumps
Figure Insulin Drug and Delivery Technologies Sales Market Share by Applications in 2017
Figure Diabetes Mellitus Type 1 Picture
Figure Diabetes Mellitus Type 2 Picture
Figure Gestational Diabetes Picture
Figure United States Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure France Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure China Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure India Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Insulin Drug and Delivery Technologies Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Sanofi Insulin Drug and Delivery Technologies Product
Table Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Sanofi Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Eli Lilly and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly and Company Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Eli Lilly and Company Insulin Drug and Delivery Technologies Product
Table Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly and Company Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Eli Lilly and Company Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Biocon Headquarter, Established, Main Business and Finance Overview (2017)
Table Biocon Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Biocon Insulin Drug and Delivery Technologies Product
Table Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biocon Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Biocon Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Julphar Headquarter, Established, Main Business and Finance Overview (2017)
Table Julphar Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Julphar Insulin Drug and Delivery Technologies Product
Table Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Julphar Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Julphar Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Ypsomed Headquarter, Established, Main Business and Finance Overview (2017)
Table Ypsomed Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Ypsomed Insulin Drug and Delivery Technologies Product
Table Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ypsomed Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Ypsomed Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Becton, Dickinson and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Becton, Dickinson and Company Insulin Drug and Delivery Technologies Production Bases, Sales Regions and Major Competitors
Table Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product
Table Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales Market Share in 2017
Figure Global Becton, Dickinson and Company Insulin Drug and Delivery Technologies Revenue Market Share in 2017
Table Global Insulin Drug and Delivery Technologies Sales by Manufacturer (2016-2017)
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2016
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2017
Table Global Insulin Drug and Delivery Technologies Revenue by Manufacturer (2016-2017)
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2016
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2017
Table Global Insulin Drug and Delivery Technologies Price by Manufacturer (2016-2017)
Figure Top 3 Insulin Drug and Delivery Technologies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Insulin Drug and Delivery Technologies Manufacturer (Revenue) Market Share in 2017
Figure Global Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Global Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Table Global Insulin Drug and Delivery Technologies Sales by Regions (2013-2018)
Table Global Insulin Drug and Delivery Technologies Sales Market Share by Regions (2013-2018)
Table Global Insulin Drug and Delivery Technologies Revenue by Regions (2013-2018)
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions in 2013
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions in 2017
Figure North America Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure North America Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Figure South America Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure South America Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Figure North America Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales Market Share by Countries (2013-2018)
Figure North America Insulin Drug and Delivery Technologies Sales Market Share by Countries in 2013
Figure North America Insulin Drug and Delivery Technologies Sales Market Share by Countries in 2017
Table North America Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
Table North America Insulin Drug and Delivery Technologies Revenue Market Share by Countries (2013-2018)
Figure North America Insulin Drug and Delivery Technologies Revenue Market Share by Countries in 2013
Figure North America Insulin Drug and Delivery Technologies Revenue Market Share by Countries in 2017
Figure United States Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Canada Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Mexico Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales by Manufacturer (2016-2017)
Figure North America Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2016
Figure North America Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2017
Table North America Insulin Drug and Delivery Technologies Revenue by Manufacturer (2016-2017)
Figure North America Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2016
Figure North America Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2017
Table North America Insulin Drug and Delivery Technologies Sales by Type (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales Share by Type (2013-2018)
Table North America Insulin Drug and Delivery Technologies Revenue by Type (2013-2018)
Table North America Insulin Drug and Delivery Technologies Revenue Share by Type (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales by Application (2013-2018)
Table North America Insulin Drug and Delivery Technologies Sales Share by Application (2013-2018)
Table North America Insulin Drug and Delivery Technologies Revenue by Application (2013-2018)
Table North America Insulin Drug and Delivery Technologies Revenue Share by Application (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales by Countries (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales Market Share by Countries (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Revenue by Countries (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Revenue Market Share by Countries in 2016
Figure Europe Insulin Drug and Delivery Technologies Revenue Market Share by Countries in 2017
Figure Germany Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure UK Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure France Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Russia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Figure Italy Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales by Manufacturer (2016-2017)
Figure Europe Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2016
Figure Europe Insulin Drug and Delivery Technologies Sales Market Share by Manufacturer in 2017
Table Europe Insulin Drug and Delivery Technologies Revenue by Manufacturer (2016-2017)
Figure Europe Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2016
Figure Europe Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturer in 2017
Table Europe Insulin Drug and Delivery Technologies Sales by Type (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales Share by Type (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Revenue by Type (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Revenue Share by Type (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales by Application (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Sales Share by Application (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Revenue by Application (2013-2018)
Table Europe Insulin Drug and Delivery Technologies Revenue Share by Application (2013-2018)
Figure Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Insulin Drug and Delivery Technologies Sales by Countries (2013-2018
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs